Trinity Biotech reported $72.69M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 23429M 810M
Bayer BAYN:GR 38.25B 5.67B
Bio Rad Laboratories BIO:US $ 3303.42M 1314.33M
Cytori Therapeutics CYTX:US $ 22.1M 2.38M
Edap Tms EDAP:US $ 66.56M 0.82M
Johnson & Johnson JNJ:US $ 60424M 555M
Mesa Laboratories MLAB:US $ 124.32M 3.32M
Orasure Technologies OSUR:US $ 268.36M 20.07M
Siemens SIE:GR 55.65B 715M
Sientra SIEN:US 134.94M 5.84M
Surmodics SRDX:US $ 64.68M 0.24M
Thermo Fisher Scientific TMO:US $ 18776M 1337M
Tosoh 4042:JP 642.28B 13.4B
Veracyte VCYT:US $ 238.48M 4.62M